Skip to content

Randomized clinical trial of standardized Boswellia cream vs. Silversulfadiazine cream on wound healing in 2nd degree burns

Randomized clinical trial of standardized Boswellia cream vs. Silversulfadiazine cream on wound healing in 2nd degree burns

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201208041605N14
Enrollment
50
Registered
2013-05-01
Start date
2012-06-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Offers traditional medicine to heal burn wounds. Condition 2: Provide a standard product from a drug- wound repair. -Burn and corrosion of trunk -Burn and corrosion of shoulder and upper limb -Burn and corrosion of wrist and hand -Burn and corrosion of hip and lower limb, except ankle and foot -Burn and corrosion of ankle and foot ? -Burn and corrosion of trunk -Burn and corrosion of shoulder and upper limb -Burn and corrosion of wrist and hand -Burn and corrosion of hip and lowe

Interventions

Intervention 1: Intervention 1: Dressing the wounds using Boswellia cream 40% (herbal resin in animal fat base) after disinfection of wounds according to standard method every other day. The end of tr
Treatment - Drugs
Intervention 1: Dressing the wounds using Boswellia cream 40% (herbal resin in animal fat base) after disinfection of wounds according to standard method every other day. The end of treatment which di
Control group: Dressing the wounds using silver sulfadiazine manufactured by Sobhan Pharmaceutical company after disinfection of wounds according to standard method every other day. The end of treatme

Sponsors

Vice-chancellorship for Research, Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients aged between 20 to 60 years old; 2nd degree burn wounds; burn surface area up to 5% Exclusion criteria: Epilepsy;Diabetes; Cardiovascular diseases; pregnancy; Breast feeding; electrical and respiratory burns

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Wound healing time. Timepoint: daily. Method of measurement: time between admission and epithelialization or preparation for skin graft.;Surface area of wounds needed to be grafted. Timepoint: daily. Method of measurement: by ruller.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Akbar Mohammadi

Shiraz University of Medical Sciences

mohamadiaa@sums.ac.ir+98 71 1821 9638

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026